BackgroundCheck.run
Search For

Jun Qi, 64Miami, FL

Related to:
Celine Yu Qingyi Yu 37 Qi Yu

Jun Qi Phones & Addresses

Miami, FL   

18 Dale St, Andover, MA 01810   

18 Dale St UNIT 5B, Andover, MA 01810   

Washington, DC   

1125 Commonwealth Ave, Allston, MA 02134    617-7832390   

Brighton, MA   

7 Woodland St, Hartford, CT 06105    860-2931654   

Work

Company: Greenberg Traurig Address:

Ranks

Licence: Connecticut - Active Date: 2004
Get Report
Control this profile

Mentions for Jun Qi

Career records & work history

Lawyers & Attorneys

Jun Qi Photo 1

Jun Qi - Lawyer

Address:
Greenberg Traurig
Licenses:
Connecticut - Active 2004
Jun Qi Photo 2

Jun Qi - Lawyer

ISLN:
923200670
Admitted:
2004

License Records

Jun Qi

Address:
Boston, MA 02210
Licenses:
License #: 30523 - Active
Issued Date: Oct 1, 2013
Expiration Date: Jun 30, 2017
Type: Certified Public Accountant

Jun Qi resumes & CV records

Resumes

Jun Qi Photo 40

Jun Qi

Jun Qi Photo 41

Jun Qi

Jun Qi Photo 42

Student At Babson College

Location:
Greater Boston Area
Education:
Babson College 2008 - 2012

Publications & IP owners

Us Patents

Compositions And Methods For Treating Neoplasia, Inflammatory Disease And Other Disorders

US Patent:
2013018, Jul 18, 2013
Filed:
May 16, 2011
Appl. No.:
13/698010
Inventors:
James Elliott Bradner - Weston MA, US
Jun Qi - Sharon MA, US
International Classification:
C07D 495/14
US Classification:
514220, 540560, 435375, 435377
Abstract:
The invention features compositions and methods for treating or preventing a neoplasia. More specifically, the invention provides compositions and methods for disrupting the interaction of a BET family polypeptide comprising a bromodomain with chromatin (e.g., disrupting a bromodomain interaction with an acetyl-lysine modification present on a histone N-terminal tail).

Male Contraceptive Compositions And Methods Of Use

US Patent:
2013021, Aug 15, 2013
Filed:
May 16, 2011
Appl. No.:
13/698006
Inventors:
James Elliott Bradner - Weston MA, US
Martin Matzuk - Houston TX, US
Jun Qi - Sharon MA, US
International Classification:
A61K 31/551
US Classification:
514220
Abstract:
The invention relates to compositions and methods for effecting male contraception.

Hdac3 Catalytic Inhibitor Development And Uses Thereof

US Patent:
2022022, Jul 21, 2022
Filed:
Jun 12, 2020
Appl. No.:
17/596466
Inventors:
- Boston MA, US
Paul Park - Waltham MA, US
Jun Qi - Sharon MA, US
Lei Wu - Boston MA, US
International Classification:
C07C 233/81
C07D 495/04
C07D 213/40
C07D 215/38
C07D 209/86
C07D 277/82
C07D 217/02
C07D 333/66
C07C 317/32
C07D 211/58
C07D 233/61
A61P 35/00
Abstract:
Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders associated with HDAC3 activity.

Compounds, Compositions, And Methods For Protein Degradation

US Patent:
2023009, Mar 30, 2023
Filed:
Feb 11, 2021
Appl. No.:
17/799000
Inventors:
- Boston MA, US
Lingling Dai - Medford MA, US
Jun Qi - Sharon MA, US
Assignee:
DANA-FARBER CANCER INSTITUTE, INC. - Boston MA
International Classification:
A61K 47/55
A61K 47/54
Abstract:
Disclosed herein are compounds that target SMARCA2, SMARCA4 or BRM, causing their degradation. Also disclosed herein are compositions and methods of use in treating associated disorders and diseases.

Acetamide Thienotriazolodiazepines And Uses Thereof

US Patent:
2021039, Dec 23, 2021
Filed:
Sep 9, 2020
Appl. No.:
17/016084
Inventors:
- Boston MA, US
Jun Qi - Sharon MA, US
Minoru Tanaka - Boston MA, US
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
A61K 31/5517
C07D 495/14
A61P 31/22
A61P 31/18
A61P 3/10
A61P 35/00
Abstract:
The present invention provides compounds of Formula (I), and pharmaceutically compositions thereof. Compounds of Formula (I) are binders of bromodomains and/or bromodomain-containing proteins (e.g., bromo and extra terminal (BET) proteins). Also provided are methods, uses, and kits using the compounds and pharmaceutical compositions for inhibiting the activity (e.g., increased activity) of bromodomains and/or bromodomain-containing proteins and for treating and/or preventing in a subject diseases associated with bromodomains or bromodomain-containing proteins (e.g., proliferative diseases, cardiovascular diseases, viral infections, fibrotic diseases, metabolic diseases, endocrine diseases, and radiation poisoning). The compounds, pharmaceutical compositions, and kits are also useful for male contraception.

Bivalent Bromodomain Inhibitors And Uses Thereof

US Patent:
2021022, Jul 22, 2021
Filed:
Dec 15, 2020
Appl. No.:
17/122258
Inventors:
- Boston MA, US
Jun Qi - Sharon MA, US
Minoru Tanaka - Boston MA, US
Justin M. Roberts - Cambridge MA, US
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
C07D 519/00
A61K 31/551
A61P 15/16
Abstract:
The present invention provides bivalent inhibitors of BET bromodomains, such as compounds of Formulae (I), (II), (III), (IV), (V), and (VI). Some bromodomain-containing proteins (e.g., BRD4) have a tandem bromodomain primary structure comprising more than one bromodomain binding site (e.g., BRD4 comprises BD1 and BD2). Bivalent inhibitors of BET bromodomains provided herein can target bromodomains through advantageous multivalent interactions, and can therefore can be to treat diseases or conditions associated with bromodomain-containing proteins. The present also provides pharmaceutical compositions and kits comprising the inventive compounds, as well as methods of using the inventive compounds.

Cyano Thienotriazolodiazepines And Uses Thereof

US Patent:
2021020, Jul 8, 2021
Filed:
Sep 9, 2016
Appl. No.:
15/758822
Inventors:
- Boston MA, US
Jun Qi - Sharon MA, US
Minoru Tanaka - Boston MA, US
Dennis Buckley - Boston MA, US
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
C07D 495/14
Abstract:
The present invention provides compounds and pharmaceutically compositions thereof. The compounds and compositions are binders of bromodomains and/or bromodomain-containing proteins (e.g., bromo and extra terminal (BET) proteins). Also provided are methods, uses, and kits using the compounds and pharmaceutical compositions for inhibiting the activity (e.g., increased activity) of bromodomains and/or bromodomain-containing proteins and for treating and/or preventing in a subject diseases associated with bromodomains or bromodomain-containing proteins (e.g., proliferative diseases, cardiovascular diseases, viral infections, fibrotic diseases, metabolic diseases, endocrine diseases, and radiation poisoning). The compounds, pharmaceutical compositions, and kits are also useful for male contraception.

Compounds And Methods For Treating Cancer

US Patent:
2021014, May 20, 2021
Filed:
Jan 26, 2021
Appl. No.:
17/158759
Inventors:
- Boston MA, US
Michael Erb - Boston MA, US
Jun Qi - Sharon MA, US
Assignee:
DANA-FARBER CANCER INSTITUTE, INC. - Boston MA
International Classification:
C07D 211/44
C07D 401/14
C07D 401/04
C07D 413/04
C07D 239/78
C07D 471/04
C07D 211/58
C07D 213/30
A61P 35/00
Abstract:
The present application relates to compounds comprising an ester, a thioester, or a hydrazide moiety and methods of synthesizing these compounds. The present application also relates to pharmaceutical compositions containing the compounds and methods of treating cell proliferative disorders mediated by the Hedgehog (Hh) signaling pathway, such as cancer, by administering the compounds and pharmaceutical compositions to subjects in need thereof.

Possible Relatives

Dave Q Qi  Emily R Qi  Fang Qi  Jian M Qi  Jianfeng Qi  Kevin S Qi  Lijun Qi  Jun Kang  Jun A Lee  Jun J Li 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.